Trials / Unknown
UnknownNCT04360707
Solid Organ Transplant Recipients With SARS-CoV-2 French Registry
Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population
Conditions
Timeline
- Start date
- 2020-04-08
- Primary completion
- 2021-04-08
- Completion
- 2021-04-08
- First posted
- 2020-04-24
- Last updated
- 2020-05-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04360707. Inclusion in this directory is not an endorsement.